- Associated Press - Updated: 8:09 p.m. on Tuesday, November 17, 2026

The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid growing indications she didn’t have the votes needed to win Senate confirmation.

Overton, a physician and White House domestic policy adviser, has spent most of her professional career working directly for Trump or conservative groups aligned with his agenda. Her nomination in August was seen as a move to bring a stabilizing Trump loyalist to the FDA after a tumultous year under Trump’s first FDA commissioner, Dr. Marty Makary.

But Overton faced bipartisan questions in the Senate about her willingness to break from Trump, particularly on his unsupported claims about the dangers of childhood vaccines.

People were interested in these podcasts

Republican Sen. Bill Cassidy, a Louisiana doctor who chairs the Senate health committee, said earlier in the day he remained undecided about Overton ahead of a critical vote on her nomination scheduled for Wednesday.

Cassidy had previously called Overton’s support for Trump’s plan to break up combination vaccines - including the measles, mumps and rubella shot- “almost disqualifying.” And he pressed her during a September hearing about her scientific independence and willingness to push back against Trump and Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic.

To win confirmation, Overton would have needed the votes of all 12 Republicans on the Senate Health, Education, Labor and Pensions Committee. Democrats hold 11 seats. Without support of the committee, Overton faced little chance of winning a full Senate vote on chamber floor.

Republicans are racing to try to confirm all of Trump’s current nominees before they hand over power to Senate Democrats in January.

Copyright © 2026 The Washington Times, LLC.

Story Topics

Please read our comment policy before commenting.